-
STRUCTURED EXPERT ELICITATION TO INFORM COST SAVINGS POTENTIALS OF A VIRTUAL TWIN FOR CAR T-CELL THERAPY FOR MULTIPLE MYELOMA
Aug 11, 2026, 17:16 PM -
HEALTH-RELATED QUALITY OF LIFE (HRQOL), HUMANISTIC AND PRODUCTIVITY BURDEN OF CAREGIVERS OF CHILDREN RECENTLY DIAGNOSED WITH TYPE 1 DIABETES (T1D): A CROSS-SECTIONAL STUDY IN THE UNITED KINGDOM (UK)
Aug 11, 2026, 17:16 PM -
CHALLENGES FOR THE ECONOMIC EVALUATION OF DIAGNOSTIC TECHNOLOGIES: A REVIEW AND TAXONOMY
Aug 11, 2026, 17:16 PM -
DEVELOPMENT OF THE RETINAL VASCULAR DISEASE QUESTIONNAIRE TO ASSESS VISUAL SYMPTOMS, VISION-RELATED IMPACTS, AND TREATMENT SATISFACTION IN DR, DME, AND NAMD
Aug 11, 2026, 17:16 PM -
DEPRESSION AND ANXIETY AS DETERMINANTS OF PATIENT-REPORTED OUTCOMES IN INFLAMMATORY ARTHRITIS: A SYSTEMATIC REVIEW WITH IMPLICATIONS FOR HEALTH ECONOMIC MODELING
Aug 11, 2026, 17:16 PM -
IMPACT OF MISSED BIOMARKER DOCUMENTATIONON REAL-WORLD EVIDENCE VALIDITY IN LUNG CANCER STUDIES
Aug 11, 2026, 17:16 PM -
COST PER QALY UP TO FIVE YEARS AFTER ICU ADMISSION AMONG ICU SURVIVORS: A MULTICENTER COHORT STUDY
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS ANALYSIS OF EXPANDING INTRANASAL INFLUENZA VACCINATION IN PAEDIATRIC HIGH-RISK POPULATIONS IN GERMANY
Aug 11, 2026, 17:16 PM -
UTILITY AND DISUTILITY VALUES FOR STROKE, MYOCARDIAL INFARCTION AND RELATED CARDIOVASCULAR HEALTH STATES: A SYSTEMATIC LITERATURE REVIEW
Aug 11, 2026, 17:16 PM -
AI AS A SECOND REVIEWER: ASSESSING A LANGUAGE MODEL'S SUITABILITY FOR ABSTRACT SCREENING IN SYSTEMATIC AND SCOPING REVIEWS
Aug 11, 2026, 17:16 PM -
RETHINKING MULTIPLE SCLEROSIS DRUG DISPENSING IN ROMANIA: A COST-CONSEQUENCE MODEL TO INFORM POLICY DECISIONS
Aug 11, 2026, 17:16 PM -
IMPACT OF SEMAGLUTIDE VERSUS TIRZEPATIDE ON WEIGHT AND BODY MASS INDEX IN PATIENTS WITH POLYENDOCRINE METABOLIC OVARIAN SYNDROME (PMOS): ANALYSIS OF US REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE, DACARBAZINE, AND DEXAMETHASONE (BRECADD) IN NEWLY DIAGNOSED ADVANCED STAGE HODGKIN LYMPHOMA FROM THE ITALY HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
REAL-WORLD DISABILITY AND BURDEN AMONG PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Aug 11, 2026, 17:16 PM -
THE HEALTH IMPACT OF PEMBROLIZUMAB FOR THE FIRST-LINE TREATMENT FOR PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER (PRMCC) IN TURKIYE
Aug 11, 2026, 17:16 PM -
AMBULATORY CARDIAC MONITORING UTILIZATION AND GUIDELINE ALIGNMENT AMONG SYMPTOMATIC ARRHYTHMIA-NAIVE PATIENTS IN ENGLAND: A REAL-WORLD EVIDENCE STUDY
Aug 11, 2026, 17:16 PM -
COST EFFECTIVENESS OF ONASEMNOGENE ABEPARVOVEC IN THE TREATMENT OF PRESYMPTOMATIC SPINAL MUSCULAR ATROPHY IN TURKIYE
Aug 11, 2026, 17:16 PM -
HEALTHCARE EXPENDITURES ASSOCIATED WITH BODY MASS INDEX IN ADULTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Aug 11, 2026, 17:16 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON OF ZILUCOPLAN VERSUS CEMDISIRAN AND GEFURULIMAB IN GENERALISED MYASTHENIA GRAVIS (GMG)
Aug 11, 2026, 17:16 PM -
NAVIGATING JOINT SCIENTIFIC CONSULTATIONS UNDER THE EU HTA REGULATION: STRATEGIC CONSIDERATIONS FOR PARALLEL VERSUS HTA-ONLY ADVICE AND ALTERNATIVE EVIDENCE ALIGNMENT APPROACHES
Aug 11, 2026, 17:16 PM
